• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Sensitivity and specificity of plasma amylin for early detection of pancreatic cancer and improvement of plasma amylin assay.

Research Project

Project/Area Number 12672260
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionFukuoka University

Principal Investigator

TATEISHI Kayoko  School of Medicine, Fukuoka University Associate Professor, 医学部, 助教授 (60179728)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2001: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2000: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsIAPP / Degradation of maylin by protease / CA-19-9 / High plasma amylin levels(5) / 血中アミリン濃度 / 膵癌腫瘍マーカー / アミリン測定法
Research Abstract

OBJECTIVE : Currently there is no simple test to detect pancreatic cancer (PC). Fasting plasma islet amyloid polypeptide (IAPP) was reported to be increased in patients with PC and a soluble factor from PC cells was reported to stimulate IAPP secretion, suggesting the possibility of an usefulness of IAPP as a marker for early detection of PC. Therefore, sensitivity and specificity of plasma IAPP in combination with CA19-9 for early detection of PC were studied. METHODS : Since IAPP is easily degraded by.proteases present in blood, plasma samples were collected in tubes containing protease inhibitors (2 mg/L antipain dihydrochloride, 25mg/L elastatinal, 0.5mg/L leupeptin and 0.5g/L EDTA). The assay system for plasma IAPP was established I (Am J Pathol 157 : 2101, 2000). RESULTS : In samples from controls, IAPPwas 1.8 - 5.9 pmol/L. Mean plasma IAPP concentration was increased in patients with PC as compared with controls (mean±SE, 7.1±0.9 vs 4.0±0.3 pmol/L). Patients with cancer of islet cell, ampullary, gallbladder and renal cell and with acute and chronic pancreatitis also showed high levels. Sensitivity and specificity of IAPP for detection of PC were 47% and 73%, respectively, when a cutoff of 6 pmol/Lwas used. IAPP was stable by 2h at 4℃ plasma in the presence of the protease inhibitors. By contrast, synthetic IAPP added to plasma containing aprotinin and EDTA, which are routinely used for estimation of other peptides, lost 16% of IAPP activity by 2hat 4℃. A combination of IAPP and CA19-9 showed a sensitivity of 85% with a specificity of 63% when either IAPP or CA19-9 was higher than each cutoff value. CONCLUSIONS : These results suggested that plasma IAPP lacks sensitivity for detection of PC and is not powerful as a tumor marker when used by itself. The difficulty of finding a tumor marker for PC may reflect heterogeneity of PC cells.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Sakagashira, S.: "S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin"American Journal of Pathology. 157. 2101-2109 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sakagashira, S.: "Compared to wild-type human amylin, S2OG mutant amylin exhibits increased cytotoxicity in transfected COS-1cells and increased amyloidogenicity in vitro"Diabetes. A401 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 立石カヨ子: "血漿アミリン(IAPP)濃度測定の膵癌診断への有用性"臨床化学. (29supp2). 296 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tateishi, K.: "Plasma islet amyloid polypeptide is not an effective marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized"Clinical Chemistry. 47. 2071-2073 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Miyasaka, K.: "Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasin factor content in conscious rats"Pancreas. 23. 414-420 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sakagashira, S.: "S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin"Am J Pathol. 157(6). 2101-2109 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Sakagashira, S.: "Compared to wild-type human amylin, S20G mutant amylin exhibits increased cytotoxicity in transfected COS-1cells and increased amyloidogenicity in vitro"Diabetes. 49(supp. 1). A401 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tateishi, K.: "Sensitivity and specificity of plasma IAPP for early detection of pancreatic cancer"Jap J Clin Chem. 29(Supp. 2). 29b (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Tateishi, K.: "Plasma islet amyloid polypeptide is not an effective marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized"Clin Chem. 47(11). 2071-2073 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Miyasaka, K.: "Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats"pancreas. 23(4). 414-420 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Setsuya Sakagashira: "S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin"American Journal Pathology. 157・6. 2101-2109 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] 立石カヨ子: "血漿アミリン(IAPP)の濃度測定の膵癌診断への有用性"臨床化学. 29・Supp.2. 296 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kayoko Tateishi: "Plasma islet amyloid polypeptide is not an effective marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized"Clinical Chemistry. 47・11. 2071-2073 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kyoko Miyasaka: "Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasin factor content in conscious rats"Pancreas. 23・4. 414-420 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Setsuya Sakagashira: "S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin"American Journal Pathology. 157・6. 2101-2109 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 立石カヨ子: "血漿アミリン(IAPP)濃度測定の膵癌診断への有用性"臨床化学. 29・Supp.2. 296 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi